|
|
||||||||||
|
J Am Coll Cardiol, 1988; 12:289-300 © 1988 by the American College of Cardiology Foundation |
Cardiovascular Research and Training Center, University of Washington, Seattle 98195.
Thrombolytic therapy for acute myocardial infarction reduces early mortality, but full recovery of left ventricular function after reperfusion is delayed. Therefore, the relations among reperfusion, survival and the time course of left ventricular functional recovery were examined in 226 patients treated with intracoronary streptokinase; 77% (134 patients) had sustained reperfusion and 31 patients had no reperfusion or had reocclusion by day 3. Wall motion was measured from contrast ventriculograms performed in the acute period and 3 days later in the central and peripheral infarct regions and the noninfarct region by the centerline method in 165 patients. Patients with reperfusion had better survival (p less than 0.05, mean follow-up 4.5 years) and a higher ejection fraction at 3 days (52 +/- 12 versus 46 +/- 10%, p less than 0.02) attributable to a significantly different change in peripheral infarct region function between the acute and 3 day studies (0.1 +/- 1.0 versus -0.3 +/- 0.9 SD, p less than 0.05). These early functional changes were significant in patients with anterior myocardial infarction and showed similar trends in those with inferior myocardial infarction. On Cox regression analysis, function measured at 3 days was more predictive of survival than was function measured acutely (chi square for acute ejection fraction = 11.48 versus 24.59 at 3 days). Although, as previously reported, greater than 45% of total recovery of left ventricular function occurs later, the ejection fraction achieved by day 3 is already predictive of survival. Thus, the mechanism by which successful thrombolytic therapy enhances survival is improvement of regional and global left ventricular function early after acute myocardial infarction.
This article has been cited by other articles:
![]() |
O. A. Centurion The Open Artery Hypothesis: Beneficial Effects and Long-term Prognostic Importance of Patency of the Infarct-Related Coronary Artery Angiology, February 1, 2007; 58(1): 34 - 44. [Abstract] [PDF] |
||||
![]() |
G. L. Raff, W. W. O'Neill, R. E. Gentry, A. Dulli, K. G. Bis, A. N. Shetty, and J. A. Goldstein Microvascular Obstruction and Myocardial Function after Acute Myocardial Infarction: Assessment by Using Contrast-enhanced Cine MR Imaging. Radiology, August 1, 2006; 240(2): 529 - 536. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Hernandez, E. J. Velazquez, S. D. Solomon, R. Kilaru, R. Diaz, C. M. O'Connor, G. Ertl, A. P. Maggioni, J.-L. Rouleau, W. van Gilst, et al. Left Ventricular Assessment in Myocardial Infarction: The VALIANT Registry Arch Intern Med, October 10, 2005; 165(18): 2162 - 2169. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J de Kam, A. A Voors, F. Fici, D. J van Veldhuisen, and W. H van Gilst Review: The revised role of ACE-inhibition after myocardial infarction in the thrombolytic/primary PCI era Journal of Renin-Angiotensin-Aldosterone System, December 1, 2004; 5(4): 161 - 168. [Abstract] [PDF] |
||||
![]() |
K Shimada, Y Sakanoue, Y Kobayashi, S Ehara, M Hirose, Y Nakamura, D Fukuda, H Yamagishi, M Yoshiyama, K Takeuchi, et al. Assessment of myocardial viability using coronary zero flow pressure after successful angioplasty in patients with acute anterior myocardial infarction Heart, January 1, 2003; 89(1): 71 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Nijland, O Kamp, P M J Verhorst, W G de Voogt, and C A Visser Early prediction of improvement in ejection fraction after acute myocardial infarction using low dose dobutamine echocardiography Heart, December 1, 2002; 88(6): 592 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Rupprecht, J. v. Dahl, W. Terres, K. M. Seyfarth, G. Richardt, H.-P. Schulthei{beta}, M. Buerke, F. H. Sheehan, and H. Drexler Cardioprotective Effects of the Na+/H+ Exchange Inhibitor Cariporide in Patients With Acute Anterior Myocardial Infarction Undergoing Direct PTCA Circulation, June 27, 2000; 101(25): 2902 - 2908. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hosokawa, F. H. Sheehan, and T. Suzuki Measurement of postsystolic shortening to assess viability and predict recovery of left ventricular function after acute myocardial infarction J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1842 - 1849. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Akasaka, K. Yoshida, T. Kawamoto, S. Kaji, Y. Ueda, A. Yamamuro, T. Takagi, and T. Hozumi Relation of Phasic Coronary Flow Velocity Characteristics With TIMI Perfusion Grade and Myocardial Recovery After Primary Percutaneous Transluminal Coronary Angioplasty and Rescue Stenting Circulation, May 23, 2000; 101(20): 2361 - 2367. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Wu, R. J. Kim, D. A. Bluemke, C. E. Rochitte, E. A. Zerhouni, L. C. Becker, and J. A. C. Lima Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1756 - 1764. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Kloner, R. Bolli, E. Marban, L. Reinlib, and E. Braunwald Medical and Cellular Implications of Stunning, Hibernation, and Preconditioning : An NHLBI Workshop Circulation, May 19, 1998; 97(18): 1848 - 1867. [Full Text] [PDF] |
||||
![]() |
M. A. Arstall, J. Yang, I. Stafford, W. H. Betts, and J. D. Horowitz N-Acetylcysteine in Combination With Nitroglycerin and Streptokinase for the Treatment of Evolving Acute Myocardial Infarction : Safety and Biochemical Effects Circulation, November 15, 1995; 92(10): 2855 - 2862. [Abstract] [Full Text] |
||||
![]() |
D. D. Miller Analytic Reviews : Detection of Viable Myocardium after Myocardial Infarction J Intensive Care Med, January 1, 1990; 5(1): 7 - 22. [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |